Disease-Free survival (DFS) 2 years [clinicaltrials_resource:9d521f74e5f262445c97187233a5c4c4]
Lenalidomide 25 mg p.o. once daily on days 1-21 plus Dexamethasone 40 mg p.o. once daily on days 1, 8, 15, and 22 of each 28-day cycle (4-weeks cycles) until CR achievement, progression of disease or intolerable toxicity
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Disease-Free survival (DFS) 2 years [clinicaltrials_resource:9d521f74e5f262445c97187233a5c4c4]
Lenalidomide 25 mg p.o. once daily on days 1-21 plus Dexamethasone 40 mg p.o. once daily on days 1, 8, 15, and 22 of each 28-day cycle (4-weeks cycles) until CR achievement, progression of disease or intolerable toxicity
Bio2RDF identifier
9d521f74e5f262445c97187233a5c4c4
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:9d521f74e5f262445c97187233a5c4c4
measure [clinicaltrials_vocabulary:measure]
Disease-Free survival (DFS)
time frame [clinicaltrials_vocabulary:time-frame]
description
Lenalidomide 25 mg p.o. once d ...... isease or intolerable toxicity
identifier
clinicaltrials_resource:9d521f74e5f262445c97187233a5c4c4
title
Disease-Free survival (DFS) 2 years
@en
type
label
Disease-Free survival (DFS) 2 ...... 21f74e5f262445c97187233a5c4c4]
@en